Eczema Therapeutics Market- Roadmap for Recovery from COVID-19 | Geopolitical Uncertainties to Boost the Market Growth | Technavio
Technavio has been monitoring the eczema therapeutics market and it is poised to grow by USD 3.60 bn during 2020-2024, progressing at a CAGR of over 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts
Frequently Asked Questions:
What are the major trends in the market?
Increasing healthcare expenditure is a major trend driving the growth of the market.
At what rate is the market projected to grow?
The year-over-year growth for 2020 is estimated at 7.09% and the incremental growth of the market is anticipated to be $ 3.60 bn.
Who are the top players in the market?
AbbVie Inc., Alliance Pharma Plc., Bausch Health Companies Inc., Bayer AG, Eli Lilly and Co., Encore Dermatology Inc., LEO Pharma AS, Mylan NV, Pfizer Inc., and Sanofi are some of the major market participants.
What are the key market drivers?
The geopolitical uncertainties is one of the major factors driving the market.
How big is the North America market?
The North America region will contribute 41% of the market share.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. AbbVie Inc., Alliance Pharma Plc., Bausch Health Companies Inc., Bayer AG, Eli Lilly and Co., Encore Dermatology Inc., LEO Pharma AS, Mylan NV, Pfizer Inc., and Sanofi are some of the major market participants. The geopolitical uncertainties will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The eczema therapeutics market report covers the following areas:
Eczema Therapeutics Market Size
Eczema Therapeutics Market Trends
Eczema Therapeutics Market Industry Analysis
This study identifies increasing healthcare expenditure as one of the prime reasons driving the eczema therapeutics market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist eczema therapeutics market growth during the next five years
Estimation of the eczema therapeutics market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the eczema therapeutics market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of eczema therapeutics market vendors
Table of Contents:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
Preface
Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
Value chain analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2019
Market size and forecast 2019-2024
Market outlook
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: CUSTOMER LANDSCAPE
PART 07: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity
PART 08: MARKET SEGMENTATION BY INDICATION
Market segmentation by indication
Comparison by indication
Atopic dermatitis - Market size and forecast 2019-2024
Contact dermatitis - Market size and forecast 2019-2024
Other indication - Market size and forecast 2019-2024
Market opportunity by indication
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Business strategies
Geopolitical uncertainties
Increasing healthcare expenditure
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
AbbVie Inc.
Alliance Pharma Plc
Bausch Health Companies, Inc.
Bayer AG
Eli Lilly and Co.
Encore Dermatology Inc.
LEO Pharma AS
Mylan NV
Pfizer Inc.
Sanofi
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The "Europe Power Supply Equipment Market for Water Electrolysis: Focus on Application, Equipment Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.
The Europe power supply equipment...
iLearningEngines Inc. ("iLearningEngines" or "the Company"), a leader in AI-powered learning automation and information intelligence for corporate and educational use, today announced that Michael Moe and Ian Davis will join the board of directors...
The "U.S. Augmented and Virtual Reality Headset Market - A Country Analysis: Focus on Application, Product, and Country - Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The U.S. augmented and virtual...
The "Global Functional Milk Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.
The global functional milk market was valued at $27.00 billion in 2023 and is expected to reach a value of $41.74 billion...
Jazz PharmaceuticalsBy Liz HendersonLiz Henderson, Sr. Vice President Technical Operations at Jazz Pharmaceuticals discusses pioneering innovation in oncology and the importance of the manufacturing infrastructure to help achieve drug development...